New study about dysregulated autoantibodies in Post COVID Syndrome published

A new study about dysregulated autoantibodies in Post COVID Syndrome (PCS) has been published in Frontiers in Immunologie! Nearly 160 patients were included in the study and divided into four groups. Most PCS patients present a plethora of symptoms without clear evidence of organ dysfunction. The symptom severity of ME/CFS correlates with natural regulatory autoantibody…

Details

CellTrend barbecue 2022

After a long break, the CellTrend barbecue party took place again on a small scale. With best weather, our guests enjoyed delicious cakes and a rich barbecue buffet from the cafeteria in the Biopark. We would like to thank all guests for the successful celebration and the GAG ​​Klausdorf for the culinary supply.

Details

Long-COVID network founded in Brandenburg

The Long-COVID-Network “DiReNa” stands for medical diagnostics, rehabilitation as well as aftercare and offers a contact point for people suffering from long-term effects of COVID-19. The 4 regional centers in Brandenburg have the necessary medical qualifications and act as contact points. For more information, please visit: www.direna.de

Details

New antibodies for Long-Covid patients

CellTrend offers new antibodies for Long-Covid patients. The PAR1 (thrombin receptor) antibody as a biomarker for thrombotic events (embolism, stroke, myocardial infarction), antibodies against the chemokine receptor CXCR3 and antibodies against the scavenger protein STABILIN-1 as risk parameters for cardiac events. These 3 new biomarkers are now available on our request form!

Details